KMID : 1146920200500050513
|
|
Journal of Pharmaceutical Investigation 2020 Volume.50 No. 5 p.513 ~ p.525
|
|
Development of amphotericin B nanosuspensions for fungal keratitis therapy: effect of self-assembled ¥ã-cyclodextrin
|
|
Jansook Phatsawee
Maw Phyo Darli Soe Hay Man Saung Hnin Chuangchunsong Ravinsinee Saiborisuth Kitisak Payonitikarn Nawaporn Autthateinchai Rinrapas Pruksakorn Patamaporn
|
|
Abstract
|
|
|
Propose: Fungal keratitis is one of the major causes in loss of vision and blindness. Amphotericin B (AmB) is the first-line treatment of keratitis caused by Candida spp. and related fungi. Due to its high molecular weight and low aqueous solubility, it hampers the ocular bioavailability. It is well-known that ¥ã-cyclodextrin (¥ãCD) can enhance AmB solubility. The aim of this study was to investigate the effect of the additives on ¥ãCD solubilization of AmB and develop AmB eye drop nanosuspensions.
Methods: 0.18% (w/v) AmB nanosuspensions containing either 0.25% (w/v) chitosan or 0.10% (w/v) phospholipids (PL) in aqueous ¥ãCD eye drop medium were prepared by using high pressure homogenization technique. Physicochemical properties, in vitro mucoadhesive, in vitro permeation, degree of AmB aggregation, hemolytic activity and in vitro antifungal test were determined.
Results: The physicochemical properties of the nanosuspensions containing AmB/¥ãCD nanoaggregates were in the acceptable range. The particle size of all formulations was in nanometer range. The degree of aggregation was less than 2.0 that meant the drug was not in the aggregate form when solubilized in ¥ãCD. These formulations demonstrated relatively low hemolytic activity and effectively improved the antifungal activity.
Conclusion: AmB/¥ãCD nanosuspension stabilized by 0.10% (w/v) PL is the promising formulation for further studies due to that it was excellent physical appearance, had mucoadhesive property, enhanced in vitro permeation, had low toxicity and improved the antifungal activity.
|
|
KEYWORD
|
|
Amphotericin B, Cyclodextrin, Nanosuspensions, Solubilizer, Aggregates
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|